Tawee Tanvetyanon

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical medicine

JCO oncology practice

Journal of adolescent and young adult oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer. Journal of clinical medicine 12 (4) (2023)
Tawee Tanvetyanon, Dung-Tsa Chen, Jhanelle E Gray
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer. Journal of clinical medicine 12 (4) (2023)
Avani M Singh, Rafael Rubiera-Pebe, Yaser Ahmad, Michael Shafique, J Kevin Hicks, Tawee Tanvetyanon
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer. JCO oncology practice (2023)
Alicia Darwin, Amber M Skinner, Damon R Reed, Tawee Tanvetyanon
Immune-Related Toxicity Among Adolescent and Young Adult with Melanoma as Compared with the Elderly. Journal of adolescent and young adult oncology 11 (6) (2022)